Reporting parties
Subject security
Symbol
ACET
Shares outstanding
9,614,829 shares
Ownership signal
SEC evidence
Form type
SCHEDULE 13G/A
Filing time
13 Apr 2026, 17:22:58 UTC
Event date
17 Feb 2026
Previous filing
17 Feb 2026
SEC filing
View on sec.gov

Key filing fact

RA CAPITAL MANAGEMENT, L.P. disclosed 12% ownership in Adicet Bio, Inc. Common Stock, par value $0.0001 per share (ACET) on 17 Feb 2026.

Key facts

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Adicet Bio, Inc. Common Stock, par value $0.0001 per share (ACET).
  • Disclosed ownership: 12%.
  • Date of event: 17 Feb 2026.

Change

  • Previous schedule filing date: 17 Feb 2026.
  • Current filing was accepted on 13 Apr 2026, 17:22.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 12% 1,182,624 0 1,182,624 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 12% 1,182,624 0 1,182,624 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 12% 1,182,624 0 1,182,624 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 12% 1,182,624 0 1,182,624 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .